Read + Share
Saito Y, Yin D, Kubota N, Wang X, et al. A therapeutically targetable TAZ-TEAD2 pathway drives the growth of
hepatocellular carcinoma via ANLN and KIF23. Gastroenterology 2023 Mar 7:S0016-5085(23)00235.
PMID: 36894036
|
 |
|
Saito Y, Yin D, Kubota N, Wang X, et al. A therapeutically targetable TAZ-TEAD2 pathway drives the growth of
hepatocellular carcinoma via ANLN and KIF23. Gastroenterology 2023 Mar 7:S0016-5085(23)00235.
PMID: 36894036
|
|
|
|